James Engelhart

Insider Reports History

Location
New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Engelhart:

Company Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Strategic Advisor Common Shares 0 $148.50 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Strategic Advisor Restricted Share Unit Award 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Strategic Advisor Stock Options (Right to buy) 0 03 Oct 2022 Direct

Insider Reports Filed by James Engelhart

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000156218022006955-engelhart-james-2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 15 -$2,361,150 4 Strategic Advisor 03 Oct 2022, 20:30
/report/000156218022000353-engelhart-james-2022-01-06 Biohaven Pharmaceutical Holding Co Ltd. 06 Jan 2022 8 -$354,578 4 Strategic Advisor 07 Jan 2022, 20:17
/report/000156218021007628-engelhart-james-2021-12-10 Biohaven Pharmaceutical Holding Co Ltd. 10 Dec 2021 5 -$3,589,146 4 Chief Financial Officer 10 Dec 2021, 19:43
/report/000156218021007300-engelhart-james-2021-11-25 Biohaven Pharmaceutical Holding Co Ltd. 25 Nov 2021 3 -$198,168 4 Chief Financial Officer 26 Nov 2021, 15:29